ClinicalTrials.Veeva

Menu

Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Invitation-only

Conditions

Prostate Cancer

Treatments

Behavioral: Mediterranean diet-based Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06935097
2025-0331
NCI-2025-02780 (Other Identifier)

Details and patient eligibility

About

This study, we will build upon our prior work and test the feasibility of a Mediterranean diet intervention for medically underserved men with prostate cancer seen at LBJ Hospital, a large safety net facility in Harris County, TX.

Full description

Primary Objectives:

To determine the feasibility of a Mediterranean diet-based intervention adapted for underrepresented minority men with prostate cancer, defined based on the following process measures68:

  • Enrollment (completion of 25 patient accrual within 2 years)
  • Retention (completion of the study through the 6-month time point, with ≥80% defined as successful)
  • Adherence (the percentage of completed study sessions and clinic visits, with ≥70% considered successful).

Secondary Objectives:

To determine changes due to the Mediterranean diet intervention in the following measures:

  • Mediterranean diet score (define using MEPA I calculated using VioScreen data)
  • Weight/BMI
  • QoL (EQ-5D-5L)
  • Physical activity (IPAS)
  • Non-invasive biomarkers
  • Gut microbiome
  • Metabolomics

To determine fidelity of intervention,62 including a description of patient comprehension, cognitive skills and perceived ability to change diet during the intervention.

Enrollment

25 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically confirmed adenocarcinoma of the prostate that is localized based on metastatic workup ordered by the treating physician (which may include CT scan, bone scan, MRI and/or other imaging). Note that metastatic workup is not required for enrollment.
  • Diagnosis within 12 months prior to enrollment OR
  • Currently managed on active surveillance, with initial biopsy being <5 years from date of enrollment
  • Self-identified Hispanic and/or Black/African American
  • Patient at LBJ Hospital

Exclusion criteria

  • Special dietary requirements such that patient is unwilling to attempt dietary change
  • Unwillingness to participate in study activities
  • Inability to keep appointments
  • Food allergy prohibitive of a Mediterranean diet, i.e. nuts allergy

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

Intervention with Mediterranean Diet
Experimental group
Description:
Twenty-five (25) self-identified Black and/or Hispanic men with newly diagnosed (within 6 months) localized PCa or who have been managed on active surveillance for less than 5 years will be enrolled along with their spouses (if applicable).
Treatment:
Behavioral: Mediterranean diet-based Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Justin Gregg, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems